Special Sources of Funds

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Download Table Data

Cooperative Research and Development Agreements (CRADAs)

Under the Federal Technology Transfer Act of 1986 (PL 99-502), government laboratories are authorized to enter into Cooperative Research and Development Agreements (CRADAs) with private sector entities. Licensing agreements are usually incorporated into the CRADA document that address patent rights attributable to research supported under the CRADA.

CRADA Receipts Deposited to the U.S. Treasury
(Dollars in Thousands)
Fiscal Year Carryover from Prior Year Collections Obligations
2005 10,962 6,858 4,253
2006 13,567 6,142 7,125
2007 12,584 9,410 8,360
2008 13,634 6,677 7,200
2009 13,111 5,466 4,765
2010 13,813 5,024 5,644
2011 13,150 8,582 5,894
2012 15,504 9,253 5,668
2013 10,587 11,226 8,470
2014 21,173 9,334 5,672
2015 24,835 15,772 11,670
2016 28,276 23,411 17,259

Royalty Income

NCI retains a portion of the royalty income generated by the patents related to NCI-funded research. A major portion of this royalty income is used to support employees of the laboratory, further scientific exchange, and provide education and training based on the terms of the Federal Technology Transfer Act (PL 99-502). Royalty income is also used to support costs associated with processing and collecting royalty income and for technology transfer efforts at NCI and NIH.

NCI Royalty Income Funding History
(Dollars in Thousands)
Years Collections* Inventor Payments Others
*Does not include assessments by NIH.
**2015/2017 and 2016/2018 payments are estimates.
2005/2007 34,086 5,745 28,341
2006/2008 29,811 6,853 22,958
2007/2009 36,344 7,210 29,134
2008/2010 50,269 8,192 42,077
2009/2011 51,621 10,225 41,396
2010/2012 58,515 5,729 52,786
2011/2013 69,155 23,271 45,884
2012/2014 84,876 33,279 51,597
2013/2015 91,324 48,433 42,891
2014/2016 112,668 33,487 82,595
**2015/2017 122,037 33,000 89,037
**2016/2018 115,093 33,000 82,093

Stamp Out Breast Cancer Act

The Stamp Out Breast Cancer Act (PL 105-41) was established in August 1997, extended in July 2000 (PL 106-253), November 2005 (PL 109-100), December 2007 (PL 110-150), December 2011 (PL 112-80), and in December 2015 (PL 114-99). This act allows postal customers to contribute funding to breast cancer research through their voluntary purchases of special rate postage stamps from the U.S. Postal Service (USPS). Of the funds collected above the postage costs and administrative costs, the Act requires the USPS to transfer 70% to NIH and 30% to the Department of Defense. As of September 2016, NCI has received $58,035,139. NCI has used these funds for research projects directed towards breast cancer research. Thus far, five major programs have been funded, including the Insight Awards to Stamp Out Breast Cancer, the Breast Cancer Research Stamp Exception Program, the Breast Cancer Premalignancy Program, a clinical trial to determine the risk of breast cancer recurrence, and the Molecular and Cellular Characterization of Screen Detected Lesions Consortium. In FY 2016, $1,654,151 million was obligated on Breast Cancer Stamp Fund programs.

  • Posted: May 15, 2017